Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3methoxy4-(methylamino)-1-pyrrolidinyl]-4-oxo-1- (2-thiazolyl)-1,8-naphthyridine-3-carbox ylic acid for treatment of antecedent hematologic disorders

Details for Australian Patent Application No. 2008335772 (hide)

Owner Sunesis Pharmaceuticals, Inc.

Inventors Michelson, Glenn

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008335772

PCT Pub. Number WO2009/075841

Priority 61/007,229 10.12.07 US

Filing date 10 December 2008

Wipo publication date 18 June 2009

International Classifications

A61K 31/4375 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/075841 Priority application(s): WO2009/075841

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008335778-In vivo unnatural amino acid expression in the methylotrophic yeast Pichia pastoris

2008335761-Inhibitors of janus kinases